Your browser doesn't support javascript.
loading
Longitudinal preclinical magnetic resonance imaging of diffuse tumor burden in intramedullary myeloma following bortezomib therapy.
Hathi, Deep K; Engelbach, John A; Hillengass, Jens; Veis, Deborah; Achilefu, Samuel; Garbow, Joel R; Shokeen, Monica.
Affiliation
  • Hathi DK; Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO, USA.
  • Engelbach JA; Department of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
  • Hillengass J; Department of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
  • Veis D; Department of Oncology, Roswell Park Comprehensive Cancer Institute, Buffalo, NY, USA.
  • Achilefu S; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
  • Garbow JR; Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO, USA.
  • Shokeen M; Department of Radiology, Washington University School of Medicine, St. Louis, MO, USA.
NMR Biomed ; 32(9): e4122, 2019 09.
Article in En | MEDLINE | ID: mdl-31206946

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Magnetic Resonance Imaging / Tumor Burden / Bortezomib / Multiple Myeloma Type of study: Guideline / Prognostic_studies Limits: Animals Language: En Journal: NMR Biomed Journal subject: DIAGNOSTICO POR IMAGEM / MEDICINA NUCLEAR Year: 2019 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Magnetic Resonance Imaging / Tumor Burden / Bortezomib / Multiple Myeloma Type of study: Guideline / Prognostic_studies Limits: Animals Language: En Journal: NMR Biomed Journal subject: DIAGNOSTICO POR IMAGEM / MEDICINA NUCLEAR Year: 2019 Document type: Article Affiliation country: United States Country of publication: United kingdom